Loading clinical trials...
Loading clinical trials...
Hypergammaglobulinaemia is frequently observed in type 1 Gaucher disease (GD1), being either polyclonal or monoclonal gammopathies. Polyclonal hypergammaglobulinemia may be related to the presence of ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hospital St. Joseph, Marseille, France
NCT07223944 · Gaucher Disease Type 1
NCT05992532 · Gaucher Disease, Acid SphingoMyelinase Deficiency
NCT03333200 · MLD, Krabbe Disease, and more
NCT06573723 · Rare Diseases, Amyloidosis, and more
NCT05487599 · Gaucher Disease, Gaucher Disease, Type 1
Internal Medicine Department, Hôpital Minjoz,
Besançon
Intensive Care Department, Hôpital Pellegrin,
Bordeaux
Internal Medicine Department, Hôpital Beaujon,
Clichy
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions